Overview

New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)

Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
This study will treat pediatric patients who have infections that are due to a specific bacteria (Vancomycin-Resistant Enterococcus)
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Linezolid
Vancomycin